Dr. Olivier Rager, an FMH nuclear medicine specialist, is distinguished for his expertise in molecular and oncological visualization. With a wealth of experience spanning years, Dr. Rager has played a crucial role in advancing the field. His notable stint as a medical researcher at the renowned Memorial Sloan-Kettering Cancer Center reflects his commitment to cutting-edge research. Engaging in several clinical studies, Dr. Rager has dedicated his efforts to enhancing the treatment of cancer patients. His focus extends to the development of advanced PET/CT and SPECT/CT molecular imaging technologies in both oncology and cardiology. Active participation in multidisciplinary symposia and membership in esteemed organizations such as the Swiss Cancer Clinical Group (SAKK) and the Society of Senology and Oncogynecology of Geneva underscore Dr. Olivier Rager's dedication to advancing nuclear medicine in the context of oncology.